Kura Oncology Inc (KURA)

R&D Expenses

$61.89M

Quarterly · Period ending: · USD

KURA logo

KURA R&D Expenses

Latest reported$61.89M
KURA Quarterly R&D Expenses ($0.00 → $61.89M)
High-resolution chart · PNG

KURA r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Kura Oncology Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
61,891,000
65,263,000
64,408,000
67,908,000
62,785,000
55,973,000
52,267,000
41,705,000
39,727,000
36,268,000
32,533,000
29,328,000
28,182,000
25,192,000
22,668,000
24,973,000
24,258,000
20,913,000
20,956,000
22,367,000
21,074,000
20,324,000
17,524,000
16,601,000
13,697,000
12,575,000
13,464,000
12,540,000
11,440,000
10,382,000
12,084,000
11,661,000
11,476,000
11,566,000
8,119,000
7,142,000
5,652,000
5,513,000
5,503,000
5,316,000
4,936,000
4,649,000
5,113,000
4,635,000
4,401,000
3,628,000
0
3,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.